Health ❯ Drug Development

Clinical Trials

Preclinical Testing FDA Approval Oral Medications Phase 3 Studies Research and Development Regulatory Approval Weight Management Antiviral Research Pain Relief Medications Efficacy Studies Neuropsychiatric Drugs Phase 3 Trials Market Approval Product Pipeline

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Analyst revisions signal a clearer 2026 growth path.

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio

Johns Hopkins Researchers Grow Vascularized Whole-Brain Organoid With Network-Level Activity

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies